US$ 28.38
glp-1 receptor agonist for weight loss PDB-101: Molecule of the Month: Agonists GLP-1 Agonists - What is
Description
hGLP-1, GLP-1, receptor agonist based on human GLP-1

OHarte, Ulster University, United Kingdom

FDA-approved for type 2 diabetes and for reducing the risk of major adverse cardiovascular events in certain adults with type 2 diabetes and established cardiovascular disease

The EMA and FDA imposed a respective label (52, 53)

35 The recent phase 3 Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis (ESSENCE) trial showed that semaglutide 2.4 mg once weekly improved liver histology in patients with metabolic dysfunction-associated steatohepatitis with moderate or advanced liver fibrosis
All of them are approved for type 2 diabetes management, and some for weight management
